The United Kingdom approves the use of the Pfizer-BioNTech coronavirus vaccine


A worker passes an undated photograph of a coronavirus disease vaccine holding a candidate for coronavirus disease (COVID-19) BNT162b2 vaccine.

Pfizer | through Reuters

The UK became the first country in the world to allow Pfizer / BioNTech coronavirus vaccination and make it available from next week.

“The government today accepted the recommendation of the Independent Medicines and Health Products Regulatory Agency (MHRA) to approve the Pfizer-BioNTech Covid-19 vaccine,” the government said on Wednesday.

“The vaccine will be available in the UK from next week.”

BioNTech, a German biotechnology developer that develops a vaccine with Pfizer, said the companies were ready to deliver the first doses to the UK immediately.

Albert Bourla, President and CEO of Pfizer, says the UK Medicines and Health Products Regulatory Agency (MHRA) license is a “historic moment”.

“Today’s emergency license in the UK is a historic moment in the fight against Covid-19. This license has been a goal we’ve been working on since we first declared science will win and applaud the MHRA for being able to carefully evaluate and take timely action to protect the UK population, ”he said.

“As we anticipate further approvals and approvals, we will focus on moving with equal urgency to deliver high-quality vaccines safely around the world. With thousands of people infected, it counts as a collective race every day to end this devastating pandemic.”

Pfizer and BioNTech announced an agreement with the UK in July for a 30 million-dose mRNA-based vaccine officially known as “BNT162b2” after it was approved for emergency use. This agreement was increased to 40 million servings in early October.

This is the latest news, please check back later.